Video Transcript:

Cannvas MedTech Inc. is the latest new listing on the Canadian Securities Exchange, trading under the symbol “MTEC”.

The company, formerly a wholly-owned subsidiary of PUF Ventures, was spun off in January 2018.

Based in Toronto, Cannvas operates in the cannabis health sciences space.

Management plans to leverage its intimate knowledge of technology and mobile applications with the new world economy of medical and recreational cannabis.

Shawn Moniz, CEO, stated: "The listing for Cannvas on the CSE represents the culmination of considerable hard work and effort by an exceptional and dedicated team who believe in the significant potential of our company and our technology. Medical cannabis has emerged to become an important economic and healthcare issue with a significant potential to improve the health and wellness of patients worldwide. Our first offering is a scalable, patient-centric life sciences learning platform for the cannabis space. From patients and consumers to medical practitioners and licensed producers, our platform will allow for global interaction and define the future face of cannabis education. By listing on the CSE, we hope to gain access to capital to grow our business and continue our journey toward becoming a leading business technology company within the cannabis space."

The company’s core platform is currently focused on preparing an online repository of medical cannabis
related information that pertains to a range of participants in the cannabis industry.